Synora Evidence home

Rigorous statistics for trials that bring in real-world data

Synora Evidence helps sponsors, foundations, and research teams design hybrid control trials and real-world evidence studies that hold up to regulatory scrutiny.

Synora Evidence: Where trials and real-world data meet

What we do

Hybrid control trials

Designs that combine randomized controls with external or real-world controls, with principled borrowing and sample size planning.

RWD and RWE study design

Fit-for-purpose real-world data studies, from data source assessment to analysis plans.

Causal inference

Methods that make treatment effect estimates credible: confounding adjustment, data integration, and sensitivity analysis.

Regulatory support

Statistical support for FDA interactions, including briefing documents, protocols, and statistical analysis plans.

Grounded in research

Synora Evidence was founded by Shu Yang, Professor of Statistics at North Carolina State University, whose research focuses on causal inference, data integration, and methods for combining randomized trials with real-world data. Read more about the founder.

Planning a trial that uses external or real-world data?

Get in touch early. Design choices made before a protocol is written, and before the first regulatory meeting, shape everything that follows.

Start a conversation